ライフサイエンスコーパス: subcutaneous adipose tissue

1 plet proteins, perilipin, and TIP47 in human subcutaneous adipose tissue.

2 old and oxidative stress decreased by 50% in subcutaneous adipose tissue.

3 accompanied by enhanced macrophage influx in subcutaneous adipose tissue.

4 g" of white fat and the healthful effects of subcutaneous adipose tissue.

5 ing and also suppressed sprouting from human subcutaneous adipose tissue.

6 that gives rise to thermogenic adipocytes in subcutaneous adipose tissue.

7 turnal hypoxemia predicted Angptl4 levels in subcutaneous adipose tissue.

8 sensitivity and, to a much lesser extent, in subcutaneous adipose tissue.

9 smooth muscle actin compared with placebo in subcutaneous adipose tissue.

10 T, but not in adjoining skeletal muscles and subcutaneous adipose tissue.

11 Similar trends were observed in subcutaneous adipose tissue.

12 liferator-activated receptor alpha/gamma) in subcutaneous adipose tissue.

13 h increased oxidative, but not ER, stress in subcutaneous adipose tissue.

14 insert columns of fat projecting up from the subcutaneous adipose tissue.

15 s in adipocytes isolated from epididymal and subcutaneous adipose tissue.

16 romes are characterized by extensive loss of subcutaneous adipose tissue.

17 functional differences between internal and subcutaneous adipose tissue.

18 t pads are morphologically similar to normal subcutaneous adipose tissue.

19 rtial lipodystrophy (FPLD), involves loss of subcutaneous adipose tissue.

20 characterized by the absence or reduction of subcutaneous adipose tissue.

21 inhibitors experience atrophy of peripheral subcutaneous adipose tissue.

22 the regulation of gene expression in porcine subcutaneous adipose tissue.

23 with that reported previously for abdominal subcutaneous adipose tissue.

24 to automatically segment the fetal body and subcutaneous adipose tissue.

25 Twist2 (-/-) patients noted deficiencies in subcutaneous adipose tissue.

26 tion of approximately 450,000 sites in human subcutaneous adipose tissue.

27 change in visceral adipose tissue (VAT) and subcutaneous adipose tissue.

28 tion by increasing AKR1C3 activity in female subcutaneous adipose tissue.

29 ful visceral adipose tissue when compared to subcutaneous adipose tissue.

30 n fat-like gene program and thermogenesis in subcutaneous adipose tissues.

31 e angiotensinogen gene is increased in their subcutaneous adipose tissues.

32 ual metabolic risk profiles for visceral and subcutaneous adipose tissues.

33 tiated preadipocytes in both human and mouse subcutaneous adipose tissues.

34 in the supraclavicular region) as well as in subcutaneous adipose tissues.

35 cm), lower volumes of abdominal superficial subcutaneous adipose tissue (-4.53 mL; 95% CI: -8.70, -0

36 female participants exhibited higher PDFF in subcutaneous adipose tissue (90.6% vs 89.7%; P < .001) a

37 xpressing Wnt-10b showed progressive loss of subcutaneous adipose tissue accompanied by dermal fibros

38 ge promoter-enhancer interaction analysis in subcutaneous adipose tissues across species suggests evo

39 o adult phantoms with (E) and without (E(0)) subcutaneous adipose tissue added to the torso for five

40 nt condition characterized by marked loss of subcutaneous adipose tissue affecting the trunk and extr

41 , decreased liver fat, and visceral and deep subcutaneous adipose tissues after 18 months of interven

42 We measured subcutaneous adipose tissue AMPK phosphorylation (threon

43 ance is lower in obese vs. lean visceral and subcutaneous adipose tissue and associates with reduced

44 tromal cells (ASCs) were isolated from human subcutaneous adipose tissue and characterized by flow cy

45 tein lipase-derived fatty acid entrapment in subcutaneous adipose tissue and forearm muscle in health

46 taneously from an abdominal vein that drains subcutaneous adipose tissue and from a radial artery.

47 s, colon, liver, monocytes, skeletal muscle, subcutaneous adipose tissue and lymphoblastoid cell line

48 etween risk of CRC and the FA composition of subcutaneous adipose tissue and product-to-precursor rat

49 nsulin resistance have lower PAHSA levels in subcutaneous adipose tissue and serum(1).

50 In contrast, after refeeding, total subcutaneous adipose tissue and skeletal muscle mass did

51 and samples of faeces, fasted venous blood, subcutaneous adipose tissue and skeletal muscle were col

52 Ectopic Wnt-10b causes loss of subcutaneous adipose tissue and TGFbeta-independent derm

53 als implicated processes in skeletal muscle, subcutaneous adipose tissue and the kidneys, respectivel

54 cyte progenitors from small samples of human subcutaneous adipose tissue and then disrupt the thermog

55 was to measure angiogenesis in visceral and subcutaneous adipose tissue and to establish whether the

56 ral and subcutaneous adipose tissue samples (subcutaneous adipose tissue and visceral adipose tissue)

57 nt depots associated with HF development are subcutaneous adipose tissue and visceral adipose tissue,

58 ucture of the lipid networks in visceral and subcutaneous adipose tissues and suggests an integrative

59 ceptor antagonist), their mRNA expression in subcutaneous adipose tissue, and circulating cortisol we

60 Volumes of whole muscle, subcutaneous adipose tissue, and IMAT were assessed by u

61 ion group had the greatest weight gain, most subcutaneous adipose tissue, and largest liver mass when

62 such as total fat mass at DXA, visceral and subcutaneous adipose tissue, and liver and pancreatic fa

63 PPARgamma is abundantly expressed in porcine subcutaneous adipose tissue, and that expression is regu

64 pression of HOXC cluster was up-regulated in subcutaneous adipose tissue, and the majority of the HOX

65 al thickness of the common carotid arteries, subcutaneous adipose tissue, and visceral adipose tissue

66 ssion quantitative trait loci genes in human subcutaneous adipose tissue, and whether expression of t

67 in resistance, suggesting that impairment of subcutaneous adipose tissue angiogenesis may contribute

68 s, and the expression of adipogenic genes in subcutaneous adipose tissue are linked to the phenotype

69 circumference (P = 0.012 to P = 0.023), and subcutaneous adipose tissue area (P = 0.016).

70 p = 0.001), with similar findings when using subcutaneous adipose tissue area as the adiposity measur

71 se tissue (PAT), extramyocellular lipids and subcutaneous adipose tissue) area measurements from 3031

72 We measured the visceral adipose tissue and subcutaneous adipose tissue areas and calculated the vis

73 Visceral adipose tissue and subcutaneous adipose tissue areas were highly correlated

74 rs to quantitate visceral adipose tissue and subcutaneous adipose tissue areas.

75 agonist action were studied ex vivo on human subcutaneous adipose tissue arterioles and endothelial c

76 s attributed to variability in the amount of subcutaneous adipose tissue as the amount of visceral fa

77 le, visceral adipose tissue (VAT), abdominal subcutaneous adipose tissue, as well as fat and iron con

78 o compare the associations between abdominal subcutaneous adipose tissue (ASAT) and visceral abdomina

79 ial function in gluteal (gSAT) and abdominal subcutaneous adipose tissue (aSAT) at baseline and in re

80 Abdominal subcutaneous adipose tissue (aSAT) biopsy samples were c

81 utaneous adipose tissue (GSAT) and abdominal subcutaneous adipose tissue (ASAT) was performed across

82 visceral adipose tissue (VAT), and abdominal subcutaneous adipose tissue (ASAT)) relative to total bo

83 ary (P=0.03) and mesenteric (P=0.04) but not subcutaneous adipose tissue augmented coronary contracti

84 Finally, we analyzed subcutaneous adipose tissue biopsies from two independen

85 ablished cultures of these cells from paired subcutaneous adipose tissue biopsies obtained before and

86 thetic nerve fibers were measured in EAT and subcutaneous adipose tissue biopsies obtained from patie

87 Subcutaneous adipose tissue biopsies were obtained after

88 ollow-up, fasted blood samples and abdominal subcutaneous adipose tissue biopsies were obtained and o

89 Muscle and subcutaneous adipose tissue biopsies were used for mRNA

90 Abdominal subcutaneous adipose tissue biopsy samples were collecte

91 Subcutaneous adipose tissue biopsy specimens were obtain

92 ominal circumference, visceral and abdominal subcutaneous adipose tissue, blood pressure, serum lipid

93 n with clinical stage T1NO breast cancer had subcutaneous adipose tissue (breast and abdominal) aspir

94 t had similar amounts of skeletal muscle and subcutaneous adipose tissue but greater visceral adipose

95 lower risk of disease, higher CRP and higher subcutaneous adipose tissue but lower liver fat for FA.

96 etic resonance imaging showed an increase in subcutaneous adipose tissue but not in visceral fat.

97 Cortisol is released from subcutaneous adipose tissue by 11beta-HSD1 in humans, an

98 one of many ectopic fat depots used when the subcutaneous adipose tissue cannot accommodate excess fa

99 assessed plasma cytokine concentrations and subcutaneous adipose tissue CD4(+) T-cell populations in

100 mma1 mRNA and PPARgamma protein abundance in subcutaneous adipose tissue compared to ad-libitum fed c

101 approximately 70% reduction in visceral and subcutaneous adipose tissues compared with ob/ob mice.

102 Femoral and abdominal subcutaneous adipose tissue compartments were unaffected

103 IRS-1, GRB14, FST, PEPD, and PDGFC) in human subcutaneous adipose tissue could be associated with inc

104 performed conditional analysis on the METSIM subcutaneous adipose tissue data to identify conditional

105 uclei Adipocyte RNA-sequencing (SNAP-seq) of subcutaneous adipose tissue defined a metabolically-acti

106 ressed differentially between mesenteric and subcutaneous adipose tissue depots and genes previously

107 and accumulate differently in mesenteric and subcutaneous adipose tissue depots, depending on the met

108 itro effects of NO on mouse 3T3-L1 and human subcutaneous adipose tissue-derived adipocytes after a c

109 , E2 is central to bone and vascular health, subcutaneous adipose tissue distribution, skeletal muscl

110 yte cultures were established from abdominal subcutaneous adipose tissue donated by healthy women und

111 se tissue (VAT)] and deep subcutaneous [deep subcutaneous adipose tissue (DSAT)] adiposity, with sign

112 The limited expandability of subcutaneous adipose tissue, due to reduced ability to r

113 ypothesis by comparing direct FFA storage in subcutaneous adipose tissue during insulin versus niacin

114 d in sympathetic innervation between EAT and subcutaneous adipose tissue, EAT showed an enhanced adre

115 function, visceral adipose tissue (VAT) and subcutaneous adipose tissue, epicardial and pericardial

116 Circulating WISP1 and WISP1 subcutaneous adipose tissue expression were regulated by

117 ese findings suggest that the propensity for subcutaneous adipose tissue FA storage is increased in p

118 During ECLL, saline is injected into the subcutaneous adipose tissue, followed by insertion of ne

119 exhibited coincident eQTLs (P < 1 x 10-5) in subcutaneous adipose tissue for BPTF and PDGFC.

120 We measured subcutaneous adipose tissue free fatty acid (FFA) storag

121 also obtained biopsy specimens of abdominal subcutaneous adipose tissue from 2 study participants wh

122 We previously identified eQTL in subcutaneous adipose tissue from 770 participants in the

123 mRNA and activity are increased in vitro in subcutaneous adipose tissue from obese patients.

124 We assessed in vivo cellular kinetics in subcutaneous adipose tissue from the abdominal (scABD) a

125 ant disorder characterized by marked loss of subcutaneous adipose tissue from the extremities and tru

126 Using proteomics, we compared subcutaneous adipose tissues from mice in these groups a

127 Paired transcriptomic analysis of gluteal subcutaneous adipose tissue (GSAT) and abdominal subcuta

128 Subcutaneous adipose tissue had a greater angiogenic cap

129 patients with higher visceral adipose tissue/subcutaneous adipose tissue had greater 90-day mortality

130 These data imply that subcutaneous adipose tissue has a higher capacity to exp

131 viduals prone to deposit visceral instead of subcutaneous adipose tissue have higher risk of metaboli

132 condyle, calvarial bone, cranial suture, and subcutaneous adipose tissue--have been engineered from m

133 ups receiving high perinatal n-6/n-3 ratios, subcutaneous adipose tissue in 14-day-old wild-type pups

134 wer in visceral adipose tissue compared with subcutaneous adipose tissue in both male and female part

135 During the development of subcutaneous adipose tissue in mice, these progenitor ce

136 Subcutaneous adipose tissue in mutant mice acquired many

137 hosphorylation (OXPHOS) capacity compared to subcutaneous adipose tissue in paired explants from subj

138 of adipocyte MCSF was then induced in rabbit subcutaneous adipose tissue in vivo using adenoviral-med

139 teric adipose tissue in Wistar lean rats but subcutaneous adipose tissue in Zucker obese rats.

140 igh ratio, waist circumference, visceral and subcutaneous adipose tissue) in well-functioning men (n

141 de, epicardial and pericardial fat, VAT, and subcutaneous adipose tissue increased stepwise from low

142 zed by a thin superficial layer of abdominal subcutaneous adipose tissue, increased visceral adipose

143 h a higher risk of mortality than was a high subcutaneous adipose tissue index.

144 ment of functional beige fat in the inguinal subcutaneous adipose tissue (ingSAT) and perigonadal vis

145 mmation, elevated adiponectin, mulitilocular subcutaneous adipose tissue (inguinal WAT) with upregula

146 the hypothesis that the ratio of visceral to subcutaneous adipose tissue is associated with altered s

147 keeping with this, progressive reduction of subcutaneous adipose tissue is commonly observed.

148 Fibrotic subcutaneous adipose tissue is metabolically dysfunction

149 Finally, human subcutaneous adipose tissues isolated from obese individ

150 nogenic primary lipodystrophy-a reduction in subcutaneous adipose tissue-it is clear that it is adipo

151 of abdominal organs, including visceral and subcutaneous adipose tissue, liver, and psoas and erecto

152 These data support an important role for a subcutaneous adipose tissue-liver axis in mediating the

153 patients with lower visceral adipose tissue/subcutaneous adipose tissue (log-rank test, linear-by li

154 n women for several traits (body mass index, subcutaneous adipose tissue, low-density lipoproteins an

155 ake if they have the ability to expand their subcutaneous adipose tissue mass, particularly in the gl

156 d that the inability to appropriately expand subcutaneous adipose tissue may be an underlying reason

157 Visceral and subcutaneous adipose tissue may contribute differentiall

158 uantitated PPARgamma mRNA splice variants in subcutaneous adipose tissue of 14 lean and 24 obese subj

159 ait locus (eQTL) analyses by using abdominal subcutaneous adipose tissue of 770 extensively phenotype

160 Expression of FSP27 in subcutaneous adipose tissue of a human diabetes cohort d

161 lso increased in epididymal, mesenteric, and subcutaneous adipose tissue of diabetic (db/db) mice and

162 containing fractions from intraabdominal and subcutaneous adipose tissue of mice revealed coordinated

163 the first demonstration of UPR activation in subcutaneous adipose tissue of obese human subjects.

164 tissue, were significantly decreased in the subcutaneous adipose tissue of obese normoglycemic and t

165 learance in adipocytes freshly isolated from subcutaneous adipose tissue of obese patients.

166 c model assessment-insulin resistance in the subcutaneous adipose tissue of obese patients.

167 eriod, whole-genome arrays were performed in subcutaneous adipose tissue of postmenopausal women (n =

168 d the in vivo effects of chronic exercise in subcutaneous adipose tissue of wild-type (WT) and endoth

169 oth PPAR gamma1 and PPAR gamma2 mRNAs in the subcutaneous adipose tissue of women compared with men.

170 chondrial DNA content, and glucose uptake in subcutaneous adipose tissue of WT but not eNOS(-/-) mice

171 e at which distal marrow adipose tissues and subcutaneous adipose tissues often reside, increases ana

172 ssion of most analyzed inflammatory genes in subcutaneous adipose tissue (P < 0.05) and increased pro

173 y eicosanoids in visceral adipose tissue and subcutaneous adipose tissue (P < 0.05).

174 in those with lower visceral adipose tissue/subcutaneous adipose tissue (p = 0.043).

175 Abdominal subcutaneous adipose tissue palmitate storage rates corr

176 se loci are indeed associated with abdominal subcutaneous adipose tissue parameters.

177 L; P < .001) and showed a higher decrease in subcutaneous adipose tissue PDFF (2.7% vs 1.5%; P < .001

178 The wireless optogenetics stimulation in the subcutaneous adipose tissue potently activates Ca(2+) cy

179 brocytes, which were similar to visceral and subcutaneous adipose tissue preadipocyte-to-adipocyte di

180 ted with increased heat production; however, subcutaneous adipose tissue provides an insulating layer

181 -3.99) for the third visceral adipose tissue/subcutaneous adipose tissue quartile compared with the f

182 egression, increased visceral adipose tissue/subcutaneous adipose tissue quartile was significantly a

183 .69) for the highest visceral adipose tissue/subcutaneous adipose tissue quartile when compared with

184 ients in the highest visceral adipose tissue/subcutaneous adipose tissue quartile.

185 A reduction in subcutaneous adipose tissue rather than VAT was associat

186 ectroscopy and visceral obesity (visceral-to-subcutaneous adipose tissue ratio >/=0.25) measured by m

187 8; P = 7 x 10(-8)) and increased visceral-to-subcutaneous adipose tissue ratio (beta = -0.015; P = 6

188 defined by a high visceral adipose tissue-to-subcutaneous adipose tissue ratio, contributes to advers

189 ated with hepatic triglyceride, VAT, and VAT/subcutaneous adipose tissue ratio.

190 but lower liver fat and a lower visceral-to-subcutaneous adipose tissue ratio.

191 nd calculated the visceral adipose tissue-to-subcutaneous adipose tissue ratio.

192 Body contouring achieved via subcutaneous adipose tissue reduction has notably advanc

193 insulin sensitivity, and losing superficial subcutaneous adipose tissue remained neutral except for

194 - 0.5% (P < 0.0001) of FFAs were taken up by subcutaneous adipose tissue, respectively.

195 Chronic VEGFR-3 signaling in Adipo-VD subcutaneous adipose tissue resulted in a reduction in t

196 s of perigonadal, perirenal, mesenteric, and subcutaneous adipose tissue revealed that the percentage

197 We used subcutaneous adipose tissue RNA-seq data from 434 Finnis

198 l-type heterogeneity in two population-level subcutaneous adipose-tissue RNA-seq datasets (TwinsUK, n

199 cluding intraabdominal adipose tissue (IAF), subcutaneous adipose tissue (SAF), trunk fat, arm fat, a

200 inflammatory gene expression in visceral and subcutaneous adipose tissue samples (subcutaneous adipos

201 In the present study, we analyzed 2,344 subcutaneous adipose tissue samples and identified 34,77

202 uantitative-trait-locus (eQTL) data in human subcutaneous adipose tissue samples confirmed that allel

203 Subcutaneous adipose tissue samples were collected and a

204 Paired visceral and subcutaneous adipose tissue samples were obtained from 1

205 Paired omental and subcutaneous adipose tissue samples were obtained from 2

206 During surgery, abdominal subcutaneous adipose tissue samples were optimally colle

207 nes regulating amino acid degradation in 200 subcutaneous adipose tissue samples.

208 SMI in cm(2)/m(2)), visceral (VAT in HU) and subcutaneous adipose tissue (SAT in HU) density predicte

209 ammasome are linked to the downregulation of subcutaneous adipose tissue (SAT) adipogenesis/lipogenes

210 It is proposed that impaired expansion of subcutaneous adipose tissue (SAT) and an increase in adi

211 sociated with increased FAM13A expression in subcutaneous adipose tissue (SAT) and an insulin resista

212 We analyzed the transcriptional profiles of subcutaneous adipose tissue (SAT) and visceral adipose t

213 AT were related to changes in the amounts of subcutaneous adipose tissue (SAT) and visceral adipose t

214 hole- and refined-grain intake and abdominal subcutaneous adipose tissue (SAT) and visceral adipose t

215 in 3,890 nondiabetic individuals; 1,882 had subcutaneous adipose tissue (SAT) and visceral adipose t

216 We examined the relations of abdominal subcutaneous adipose tissue (SAT) and visceral adipose t

217 dominal ultrasonography determined abdominal subcutaneous adipose tissue (SAT) and visceral adipose t

218 ficant increase in the number of CLS in both subcutaneous adipose tissue (SAT) and visceral adipose t

219 Subcutaneous adipose tissue (SAT) and visceral adipose t

220 as an impact on gene expression in abdominal subcutaneous adipose tissue (SAT) and whether changes in

221 effect of visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) area on metabolic synd

222 ies, cortical bone densities, VAT areas, and subcutaneous adipose tissue (SAT) areas at vertebral lev

223 abdominal visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) between white and Afri

224 es between visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) compartments, particul

225 Preferential energy storage in subcutaneous adipose tissue (SAT) confers protection aga

226 e tissue (VAT) tends to increase, peripheral subcutaneous adipose tissue (SAT) decreases significantl

227 m with mean anterior and posterior abdominal subcutaneous adipose tissue (SAT) depths of 1.6 and 2.0

228 fibrillar collagen is essential for adaptive subcutaneous adipose tissue (SAT) expansion that protect

229 adipose tissue, visceral adipose tissue, and subcutaneous adipose tissue (SAT) from baseline to 6 and

230 In contrast, subcutaneous adipose tissue (SAT) growth and morphology

231 XRbeta, also repress the browning process of subcutaneous adipose tissue (SAT) in male rodents fed a

232 sue (VAT), and pre- and postcold PDFF of the subcutaneous adipose tissue (SAT) in the posterior neck

233 tor-1alpha (PPARGC1A) in skeletal muscle and subcutaneous adipose tissue (SAT) is suggested to play a

234 TSP1 gene expression was quantified in subcutaneous adipose tissue (SAT) of 86 nondiabetic subj

235 d data suggest that the effects of abdominal subcutaneous adipose tissue (SAT) on cardiovascular dise

236 Proper storage of excessive dietary fat into subcutaneous adipose tissue (SAT) prevents ectopic lipid

237 Here we examined subcutaneous adipose tissue (SAT) samples from healthy m

238 VAT and subcutaneous adipose tissue (SAT) samples obtained from

239 Visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) vary in volume and qua

240 y we show that ERbeta influences browning of subcutaneous adipose tissue (SAT) via its actions both o

241 Subcutaneous adipose tissue (SAT) volume, visceral adipo

242 ects of rhGH on insulin sensitivity (SI) and subcutaneous adipose tissue (SAT) volume.

243 Visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) was quantified by magn

244 Visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) were measured at the L

245 l muscle, visceral adipose tissue (VAT), and subcutaneous adipose tissue (SAT) were measured using cr

246 nsities of visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) were quantified from d

247 densities of visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), and intermuscular adi

248 increases in visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), and intermuscular adi

249 or BMI >=25), visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), and VAT/SAT ratio.

250 mRNA or protein levels were higher in liver, subcutaneous adipose tissue (SAT), and visceral adipose

251 16243 (CL)-stimulated thermogenic program in subcutaneous adipose tissue (SAT), but not in visceral f

252 ate associations between soft-tissue markers subcutaneous adipose tissue (SAT), intermuscular adipose

253 at, visceral adipose tissue (VAT), abdominal subcutaneous adipose tissue (SAT), total adipose tissue,

254 d SM, bone, epicardial adipose tissue (EAT), subcutaneous adipose tissue (SAT), visceral adipose tiss

255 Abdominal subcutaneous adipose tissue (SAT), visceral adipose tiss

256 ition or lipodystrophy, leading to losses of subcutaneous adipose tissue (SAT).

257 r bundles (NFBs) residing in mouse and human subcutaneous adipose tissue (SAT).

258 -body SM, visceral adipose tissue (VAT), and subcutaneous adipose tissue (SAT).

259 vs. low visceral adipose tissue [VAT]/[VAT + subcutaneous adipose tissue (SAT)] ratio), independent o

260 sue (VAT)] rather than in subcutaneous ones [subcutaneous adipose tissue (SAT)].

261 depots beneath the fascia of muscles (versus subcutaneous adipose tissue [SAT]) may precede insulin r

262 partment segmentation (skeletal muscle [SM], subcutaneous adipose tissue [SAT], and visceral adipose

263 We measured visceral (VAT) and subcutaneous adipose tissue (SCAT) areas at midwaist in

264 ort a role for adipogenesis-related genes in subcutaneous adipose tissue sex differences in the genet

265 Similar relationships were found in human subcutaneous adipose tissue stained for the macrophage a

266 Subcutaneous adipose tissue stores excess lipids and mai

267 In subcutaneous adipose tissue, taurine decreased ethanol-i

268 le closely matched the fatty acid profile of subcutaneous adipose tissue TGs during epinephrine infus

269 centrations of alpha-linolenic acid in their subcutaneous adipose tissue than did controls.

270 patients with higher visceral adipose tissue/subcutaneous adipose tissue than in those with lower vis

271 expressed and secreted from visceral but not subcutaneous adipose tissue that increases insulin sensi

272 Subcutaneous adipose tissue TIMP3 expression correlated

273 OS-derived NO in the metabolic adaptation of subcutaneous adipose tissue to exercise training.

274 of body composition parameters (visceral and subcutaneous adipose tissue, total adipose tissue, total

275 We investigated sex differences in subcutaneous adipose tissue transcriptional regulation u

276 se was measured in the interstitial space of subcutaneous adipose tissue using microdialysis, and 39

277 ic subpopulation of cells derived from human subcutaneous adipose tissue utilizing microfluidic-based

278 weight, and volume of abdominal visceral and subcutaneous adipose tissue (VAT and SAT).

279 Abdominal subcutaneous adipose tissue volume [beta = 0.432, (95% C

280 patients with higher visceral adipose tissue/subcutaneous adipose tissue was found for both patients

281 The ratio of visceral to subcutaneous adipose tissue was greater in both men (P <

282 Visceral adipose tissue/subcutaneous adipose tissue was not correlated with body

283 001), respectively; no significant change in subcutaneous adipose tissue was observed.

284 dermal fibrosis was observed and part of the subcutaneous adipose tissue was replaced by connective t

285 f our published dataset of 37 subjects whose subcutaneous adipose tissue was sampled before and after

286 Subcutaneous adipose tissue was taken from seven healthy

287 sue deposited on the sensor and nonimplanted subcutaneous adipose tissue was then collected for histo

288 t, the expression of inflammatory markers in subcutaneous adipose tissue was unchanged postoperativel

289 cells show extensive inflammation and limit subcutaneous adipose tissue wasting, independently of pa

290 endothelial cells (LECs) from human skin and subcutaneous adipose tissue, we identified various LEC s

291 Sex differences in associations with subcutaneous adipose tissue were identified.

292 Computed tomography scans of VAT and subcutaneous adipose tissue were performed by imaging a

293 Paired samples of epicardial and subcutaneous adipose tissues were harvested at the outse

294 mference, visceral adipose tissue [VAT], and subcutaneous adipose tissue) were assessed with anthropo

295 ttenuation attributes of skeletal muscle and subcutaneous adipose tissue, were derived from baseline

296 s, along with the expression of key genes in subcutaneous adipose tissue, were not statistically diff

297 f fructose within other organs, specifically subcutaneous adipose tissue, which is the largest metabo

298 -throughput/sensitivity proteome analyses in subcutaneous adipose tissue with biochemical blood measu

299 ating fatty acids and increased expansion of subcutaneous adipose tissue with chronic high fat diet (

300 ted with improved lipid profile, losing deep subcutaneous adipose tissue with improved insulin sensit